Labcorp Upgrades Global Trial Connect Platform to Streamline Research

The enhancements target the specific pain points of modern clinical research, where managing data across fragmented systems often delays patient-centric outcomes. By implementing a unified Study Oversight Dashboard, the platform now consolidates site, sample, and supply insights, allowing teams to move away from manual coordination. A notable technical improvement includes an in-portal kit ordering system, which the company claims reduces manual data entry by 75 percent.

Brian Caveney, Labcorp’s chief medical and scientific officer, noted that the platform’s redesign prioritizes efficiency to ensure researchers spend less time on operational logistics and more on scientific advancement. The rollout follows a cycle of testing with sponsors and investigator sites worldwide, aiming to provide a more cohesive digital architecture as trial complexity continues to mount across the pharmaceutical sector.